BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 20059481)

  • 1. Islet inflammation and CXCL10 in recent-onset type 1 diabetes.
    Roep BO; Kleijwegt FS; van Halteren AG; Bonato V; Boggi U; Vendrame F; Marchetti P; Dotta F
    Clin Exp Immunol; 2010 Mar; 159(3):338-43. PubMed ID: 20059481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.
    Tanaka S; Nishida Y; Aida K; Maruyama T; Shimada A; Suzuki M; Shimura H; Takizawa S; Takahashi M; Akiyama D; Arai-Yamashita S; Furuya F; Kawaguchi A; Kaneshige M; Katoh R; Endo T; Kobayashi T
    Diabetes; 2009 Oct; 58(10):2285-91. PubMed ID: 19641142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
    PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine.
    Pöysti S; Silojärvi S; Brodnicki TC; Catterall T; Liu X; Mackin L; Luster AD; Kay TWH; Christen U; Thomas HE; Hänninen A
    J Autoimmun; 2023 Nov; 140():103090. PubMed ID: 37572540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients.
    Dotta F; Censini S; van Halteren AG; Marselli L; Masini M; Dionisi S; Mosca F; Boggi U; Muda AO; Del Prato S; Elliott JF; Covacci A; Rappuoli R; Roep BO; Marchetti P
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5115-20. PubMed ID: 17360338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction.
    Ylipaasto P; Smura T; Gopalacharyulu P; Paananen A; Seppänen-Laakso T; Kaijalainen S; Ahlfors H; Korsgren O; Lakey JR; Lahesmaa R; Piemonti L; Oresic M; Galama J; Roivainen M
    Diabetologia; 2012 Dec; 55(12):3273-83. PubMed ID: 22983635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetes.
    Aida K; Nishida Y; Tanaka S; Maruyama T; Shimada A; Awata T; Suzuki M; Shimura H; Takizawa S; Ichijo M; Akiyama D; Furuya F; Kawaguchi A; Kaneshige M; Itakura J; Fujii H; Endo T; Kobayashi T
    Diabetes; 2011 Mar; 60(3):884-9. PubMed ID: 21289206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
    Christen U; Kimmel R
    Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enterovirus markers and serum CXCL10 in children with type 1 diabetes.
    Berg AK; Tuvemo T; Frisk G
    J Med Virol; 2010 Sep; 82(9):1594-9. PubMed ID: 20648615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes.
    Uno S; Imagawa A; Saisho K; Okita K; Iwahashi H; Hanafusa T; Shimomura I
    Endocr J; 2010; 57(11):991-6. PubMed ID: 20966598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR3, CXCL10 and type 1 diabetes.
    Antonelli A; Ferrari SM; Corrado A; Ferrannini E; Fallahi P
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):57-65. PubMed ID: 24529741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1.
    Richardson SJ; Leete P; Bone AJ; Foulis AK; Morgan NG
    Diabetologia; 2013 Jan; 56(1):185-93. PubMed ID: 23064357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule CXCR3 antagonist NIBR2130 has only a limited impact on type 1 diabetes in a virus-induced mouse model.
    Christen S; Holdener M; Beerli C; Thoma G; Bayer M; Pfeilschifter JM; Hintermann E; Zerwes HG; Christen U
    Clin Exp Immunol; 2011 Sep; 165(3):318-28. PubMed ID: 21649647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis.
    Morimoto J; Yoneyama H; Shimada A; Shigihara T; Yamada S; Oikawa Y; Matsushima K; Saruta T; Narumi S
    J Immunol; 2004 Dec; 173(11):7017-24. PubMed ID: 15557199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterovirus infection induces cytokine and chemokine expression in insulin-producing cells.
    Nair S; Leung KC; Rawlinson WD; Naing Z; Craig ME
    J Med Virol; 2010 Nov; 82(11):1950-7. PubMed ID: 20872723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathology of the human pancreas in type-I diabetes.
    Richardson SJ; Willcox A; Bone AJ; Morgan NG; Foulis AK
    Semin Immunopathol; 2011 Jan; 33(1):9-21. PubMed ID: 20424842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
    Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
    Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease.
    Christen U; McGavern DB; Luster AD; von Herrath MG; Oldstone MB
    J Immunol; 2003 Dec; 171(12):6838-45. PubMed ID: 14662890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.
    Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F
    Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes.
    Ploix C; Bergerot I; Fabien N; Perche S; Moulin V; Thivolet C
    Diabetes; 1998 Jan; 47(1):39-44. PubMed ID: 9421372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.